Anxo Pharmaceutical Co., Ltd. (6677.TWO)

TWD 19.0

(4.68%)

EBITDA Summary of Anxo Pharmaceutical Co., Ltd.

  • Anxo Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 131.31 Million TWD , up 54.36% from previous year.
  • Anxo Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was -2.52 Million TWD , down -278.54% from previous quarter.
  • Anxo Pharmaceutical Co., Ltd. reported an annual EBITDA of 84.96 Million TWD in 2022, down -23.61% from previous year.
  • Anxo Pharmaceutical Co., Ltd. reported an annual EBITDA of 111.21 Million TWD in 2021, down -22.9% from previous year.
  • Anxo Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 1.41 Million TWD for 2024 Q1, down -95.49% from previous quarter.
  • Anxo Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 25.23 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Anxo Pharmaceutical Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Anxo Pharmaceutical Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 131.31 Million TWD 54.36%
2022 84.96 Million TWD -23.61%
2021 111.21 Million TWD -22.9%
2020 144.24 Million TWD 23.2%
2019 117.08 Million TWD 0.0%

Peer EBITDA Comparison of Anxo Pharmaceutical Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 35.881%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 43.179%
Easywell Biomedicals, Inc. -85.5 Million TWD 253.577%
TTY Biopharm Company Limited 1.52 Billion TWD 91.386%
Synmosa Biopharma Corporation 1 Billion TWD 86.983%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 77.474%
Center Laboratories, Inc. -175.17 Million TWD 174.961%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -322.926%
Orient Pharma Co., Ltd. 172.39 Million TWD 23.832%
InnoPharmax Inc. -62.12 Million TWD 311.381%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -3.657%
Excelsior Biopharma Inc. -29.36 Million TWD 547.104%
DV Biomed Co., Ltd. 407.64 Million TWD 67.788%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 114.396%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 83.643%
UniPharma Co., Ltd. -16.25 Million TWD 907.863%
Alar Pharmaceuticals Inc. 394.52 Million TWD 66.717%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 42.49%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 436.399%
Bioray Biotech Co., Ltd 12.13 Million TWD -982.077%
TSH Biopharm Corporation Limited 99.35 Million TWD -32.169%